UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
x |
Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended: June 30, 2015
¨ |
Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from _____ to _____.
Commission File Number: 0-19672
American Superconductor Corporation
(Exact name of registrant as specified in its charter)
Delaware |
|
04-2959321 |
|
(State or other jurisdiction of |
|
(I.R.S. Employer |
|
|
|
|
|
64 Jackson Road, Devens, Massachusetts |
|
01434 |
|
(Address of principal executive offices) |
|
(Zip Code) |
(978) 842-3000
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ¨ |
|
Accelerated filer x |
|
Non-accelerated filer ¨ |
|
Smaller reporting company ¨ |
|
|
|
|
(Do not check if a smaller reporting company) |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
Shares outstanding of the Registrant’s common stock:
Common Stock, par value $0.01 per share |
|
13,953,647 |
Class |
|
Outstanding as of July 31, 2015 |
AMERICAN SUPERCONDUCTOR CORPORATION
INDEX
|
Page No. |
||
PART I—FINANCIAL INFORMATION |
|
||
|
|
|
|
Item 1. |
|
3 |
|
|
|
|
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
25 |
|
|
|
|
Item 3. |
|
34 |
|
|
|
|
|
Item 4. |
|
35 |
|
|
|
||
PART II—OTHER INFORMATION |
|
||
|
|
|
|
Item 1. |
|
35 |
|
|
|
|
|
Item 1A. |
|
37 |
|
|
|
|
|
Item 2. |
|
37 |
|
|
|
|
|
Item 3. |
|
37 |
|
|
|
|
|
Item 4. |
|
37 |
|
|
|
|
|
Item 5. |
|
37 |
|
|
|
|
|
Item 6. |
|
37 |
|
|
|
||
38 |
2
AMERICAN SUPERCONDUCTOR CORPORATION
PART I — FINANCIAL INFORMATION
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
|
June 30, |
|
|
March 31, |
|
||
|
2015 |
|
|
2015 |
|
||
ASSETS |
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
38,561 |
|
|
$ |
20,490 |
|
Accounts receivable, net |
|
8,491 |
|
|
|
9,879 |
|
Inventory |
|
17,080 |
|
|
|
20,596 |
|
Prepaid expenses and other current assets |
|
9,726 |
|
|
|
10,764 |
|
Restricted cash |
|
3,269 |
|
|
|
2,822 |
|
Total current assets |
|
77,127 |
|
|
|
64,551 |
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
54,421 |
|
|
|
56,097 |
|
Intangibles, net |
|
1,280 |
|
|
|
1,422 |
|
Restricted cash |
|
795 |
|
|
|
1,236 |
|
Deferred tax assets |
|
7,766 |
|
|
|
7,766 |
|
Other assets |
|
1,526 |
|
|
|
2,753 |
|
|
|
|
|
|
|
|
|
Total assets |
$ |
142,915 |
|
|
$ |
133,825 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
Accounts payable and accrued expenses |
$ |
18,645 |
|
|
$ |
21,615 |
|
Note payable, current portion, net of discount of $190 as of June 30, 2015 and $244 as of March 31, 2015 |
|
3,810 |
|
|
|
3,756 |
|
Derivative liabilities |
|
2,198 |
|
|
|
2,999 |
|
Deferred revenue |
|
9,388 |
|
|
|
11,019 |
|
Deferred tax liabilities |
|
7,843 |
|
|
|
7,843 |
|
Total current liabilities |
|
41,884 |
|
|
|
47,232 |
|
|
|
|
|
|
|
|
|
Note payable, net of discount of $233 as of June 30, 2015 and $290 as of March 31, 2015 |
|
2,934 |
|
|
|
3,877 |
|
Deferred revenue |
|
3,387 |
|
|
|
2,756 |
|
Other liabilities |
|
90 |
|
|
|
67 |
|
Total liabilities |
|
48,295 |
|
|
|
53,932 |
|
|
|
|
|
|
|
|
|
Commitments and contingencies (Note 13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
Common stock |
|
140 |
|
|
|
96 |
|
Additional paid-in capital |
|
1,009,393 |
|
|
|
985,921 |
|
Treasury stock, at cost |
|
(869 |
) |
|
|
(771 |
) |
Accumulated other comprehensive income (loss) |
|
122 |
|
|
|
(308 |
) |
Accumulated deficit |
|
(914,166 |
) |
|
|
(905,045 |
) |
Total stockholders' equity |
|
94,620 |
|
|
|
79,893 |
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity |
$ |
142,915 |
|
|
$ |
133,825 |
|
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
3
AMERICAN SUPERCONDUCTOR CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
|
Three months ended June 30, |
|
|
|
|||||
|
2015 |
|
|
2014 |
|
|
|
||
|
|
|
|
|
|
|
|
|
|
Revenues |
$ |
23,723 |
|
|
$ |
11,696 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost and operating expenses: |
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
20,503 |
|
|
|
12,087 |
|
|
|
Research and development |
|
3,162 |
|
|
|
3,120 |
|
|
|
Selling, general and administrative |
|
7,535 |
|
|
|
7,938 |
|
|
|
Restructuring and impairments |
|
741 |
|
|
|
1,179 |
|
|
|
Amortization of acquisition related intangibles |
|
39 |
|
|
|
39 |
|
|
|
Total operating expenses |
|
31,980 |
|
|
|
24,363 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
(8,257 |
) |
|
|
(12,667 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of derivatives and warrants |
|
800 |
|
|
|
(35 |
) |
|
|
Interest expense, net |
|
(318 |
) |
|
|
(535 |
) |
|
|
Other expense, net |
|
(772 |
) |
|
|
(152 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income tax expense |
|
(8,547 |
) |
|
|
(13,389 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
574 |
|
|
|
128 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
$ |
(9,121 |
) |
|
$ |
(13,517 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share |
|
|
|
|
|
|
|
|
|
Basic |
$ |
(0.75 |
) |
|
$ |
(1.74 |
) |
|
|
Diluted |
$ |
(0.75 |
) |
|
$ |
(1.74 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding |
|
|
|
|
|
|
|
|
|
Basic |
|
12,111 |
|
|
|
7,769 |
|
|
|
Diluted |
|
12,111 |
|
|
|
7,769 |
|
|
|
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
4
AMERICAN SUPERCONDUCTOR CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
(In thousands)
|
Three months ended June 30, |
|
|||||
|
2015 |
|
|
2014 |
|
||
|
|
|
|
|
|
|
|
Net loss |
$ |
(9,121 |
) |
|
$ |
(13,517 |
) |
|
|
|
|
|
|
|
|
Other comprehensive (loss) income, net of tax: |
|
|
|
|
|
|
|
Foreign currency translation (losses) gains |
|
430 |
|
|
|
(101 |
) |
Total other comprehensive (loss) income, net of tax |
|
430 |
|
|
|
(101 |
) |
Comprehensive loss |
$ |
(8,691 |
) |
|
$ |
(13,618 |
) |
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
5
AMERICAN SUPERCONDUCTOR CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
|
Three months ended June 30, |
|||||||
|
|
2015 |
|
|
|
2014 |
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net loss |
$ |
(9,121 |
) |
|
$ |
(13,517 |
) |
|
Adjustments to reconcile net loss to net cash used in operations: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
2,028 |
|
|
|
2,475 |
|
|
Stock-based compensation expense |
|
1,128 |
|
|
|
1,581 |
|
|
Impairment of long-lived and intangible assets |
|
746 |
|
|
|
- |
|
|
Provision for excess and obsolete inventory |
|
602 |
|
|
|
649 |
|
|
Write-off prepaid taxes |
|
820 |
|
|
|
- |
|
|
Loss on minority interest investments |
|
356 |
|
|
|
202 |
|
|
Change in fair value of derivatives and warrants |
|
(800 |
) |
|
|
35 |
|
|
Non-cash interest expense |
|
111 |
|
|
|
190 |
|
|
Other non-cash items |
|
553 |
|
|
|
49 |
|
|
Changes in operating asset and liability accounts: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
1,414 |
|
|
|
(2,741 |
) |
|
Inventory |
|
2,968 |
|
|
|
623 |
|
|
Prepaid expenses and other current assets |
|
271 |
|
|
|
441 |
|
|
Accounts payable and accrued expenses |
|
(3,024 |
) |
|
|
(1,344 |
) |
|
Deferred revenue |
|
(1,087 |
) |
|
|
5,851 |
|
|
Net cash used in operating activities |
|
(3,035 |
) |
|
|
(5,506 |
) |
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchase of property, plant and equipment |
|
(197 |
) |
|
|
(287 |
) |
|
Proceeds from the sale of property, plant and equipment |
|
7 |
|
|
|
5 |
|
|
Change in restricted cash |
|
(4 |
) |
|
|
108 |
|
|
Change in other assets |
|
130 |
|
|
|
(93 |
) |
|
Net cash used in investing activities |
|
(64 |
) |
|
|
(267 |
) |
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Employee taxes paid related to net settlement of equity awards |
|
(98 |
) |
|
|
(368 |
) |
|
Repayment of debt |
|
(1,000 |
) |
|
|
(1,442 |
) |
|
Proceeds from public equity offering, net |
|
22,281 |
|
|
|
1,177 |
|
|
Net cash provided by (used in) financing activities |
|
21,183 |
|
|
|
(633 |
) |
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents |
|
(13 |
) |
|
|
(84 |
) |
|
|
|
|
|
|
|
|
|
|
Net increase/(decrease) in cash and cash equivalents |
|
18,071 |
|
|
|
(6,490 |
) |
|
Cash and cash equivalents at beginning of year |
|
20,490 |
|
|
|
43,114 |
|
|
Cash and cash equivalents at end of year |
$ |
38,561 |
|
|
$ |
36,624 |
|
|
|
|
|
|
|
|
|
|
|
Supplemental schedule of cash flow information: |
|
|
|
|
|
|
|
|
Cash paid for income taxes, net of refunds |
$ |
329 |
|
|
$ |
34 |
|
|
Issuance of common stock to settle liabilities |
|
107 |
|
|
|
1,431 |
|
|
Cash paid for interest |
|
220 |
|
|
|
368 |
|
|
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
6
AMERICAN SUPERCONDUCTOR CORPORATION
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Nature of the Business and Operations and Liquidity
Nature of the Business and Operations
American Superconductor Corporation (“AMSC” or the “Company”) was founded on April 9, 1987. The Company is a leading provider of megawatt-scale solutions that lower the cost of wind power and enhance the performance of the power grid. In the wind power market, the Company enables manufacturers to field wind turbines through its advanced engineering, support services and power electronics products. In the power grid market, the Company enables electric utilities and renewable energy project developers to connect, transmit and distribute power through its transmission planning services and power electronics and superconductor-based products. The Company’s wind and power grid products and services provide exceptional reliability, security, efficiency and affordability to its customers.
These unaudited condensed consolidated financial statements of the Company have been prepared on a going concern basis in accordance with United States generally accepted accounting principles (“GAAP”) and the Securities and Exchange Commission’s (“SEC”) instructions to Form 10-Q. The going concern basis of presentation assumes that the Company will continue operations and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to those instructions. The year-end condensed balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The unaudited condensed consolidated financial statements, in the opinion of management, reflect all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the results for the interim periods ended June 30, 2015 and 2014 and the financial position at June 30, 2015.
On March 24, 2015, the Company effected a 1-for-10 reverse stock split of its common stock. Trading of the Company’s common stock reflected the reverse stock split beginning on March 25, 2015. Unless otherwise indicated, all historical references to shares of common stock, shares of restricted stock, restricted units, shares underlying options, warrants or calculations that use common stock for per share financial reporting have been adjusted for comparative purposes to reflect the impact of the 1-for-10 reverse stock split as if it had occurred at the beginning of the earliest period presented.
Liquidity
The Company has experienced recurring operating losses and as of June 30, 2015, the Company had an accumulated deficit of $914.2 million. In addition, the Company has experienced recurring negative operating cash flows. At June 30, 2015, the Company had cash and cash equivalents of $38.6 million. Cash used in operations for the three months ended June 30, 2015 was $3.0 million.
From April 1, 2011 through the date of this filing, the Company has reduced its global workforce substantially. The Company is currently in the process of consolidating certain business operations to reduce facility costs. As of June 30, 2015, the Company had a global workforce of 308 persons. The Company plans to closely monitor its expenses and if required, expects to further reduce operating costs and capital spending to enhance liquidity.
Over the last several years, the Company has entered into several debt and equity financing arrangements in order to enhance liquidity. Since April 1, 2012, the Company has generated aggregate cash flows from financing activities of $74.0 million. This amount includes proceeds from an April 2015 equity offering, which generated net proceeds of approximately $22.3 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. See Note 10, “Debt”, and Note 12 “Stockholders Equity” for further discussion of these financing arrangements. The Company believes that it is in compliance with the covenants and restrictions included in the agreements governing its debt arrangements as of June 30, 2015.
The Company believes it has sufficient liquidity to fund its operations, capital expenditures and scheduled cash payments under its debt obligations for the next twelve months. The Company’s liquidity is highly dependent on, its ability to increase revenues, its ability to control its operating costs, its ability to maintain compliance with the covenants and restrictions on its debt obligations (or obtain waivers from its lender in the event of non-compliance), and its ability to raise additional capital, if necessary. There can be no assurance that the Company will be able to continue to raise additional capital from other sources or execute on any other means of improving liquidity described above.
The Company no longer believes its investments in Tres Amigas, LLC, a Delaware limited liability company (“Tres Amigas”) or Blade Dynamics Ltd. (“Blade Dynamics”) are recoverable. The Company fully impaired its remaining investments in both, recording a charge of $0.7 million during the three months ended June 30, 2015 for Tres Amigas and $3.5 million in the three months ended September 30, 2014 for Blade Dynamics. (See Note 14, “Minority Investments”, for further information about such investments).
7
2. Stock-Based Compensation
The Company accounts for its stock-based compensation at fair value. The following table summarizes stock-based compensation expense by financial statement line item for the three months ended June 30, 2015 and 2014 (in thousands):
|
Three months ended June 30, |
|
|||||
|
2015 |
|
|
2014 |
|
||
Cost of revenues |
$ |
97 |
|
|
$ |
153 |
|
Research and development |
|
196 |
|
|
|
479 |
|
Selling, general and administrative |
|
835 |
|
|
|
949 |
|
Total |
$ |
1,128 |
|
|
$ |
1,581 |
|
During the three months ended June 30, 2015, the Company granted 364,695 restricted stock awards. These awards generally vest over 3 years. During the three months ended June 30, 2014, the Company granted approximately 100,000 stock options and 97,233 restricted stock awards. The stock options vest over 5 years, and the restricted stock awards vest over one year. For options and awards that vest upon the passage of time, expense is being recorded over the vesting period. Performance-based restricted stock awards are expensed over the requisite service period based on probability of achievement.
The estimated fair value of the Company’s stock-based awards, less expected annual forfeitures, is amortized over the awards’ service period. The total unrecognized compensation cost for unvested outstanding stock options was $1.0 million at June 30, 2015. This expense will be recognized over a weighted average expense period of approximately 2.8 years. The total unrecognized compensation cost for unvested outstanding restricted stock was $3.9 million at June 30, 2015. This expense will be recognized over a weighted-average expense period of approximately 2.5 years.
The weighted-average assumptions used in the Black-Scholes valuation model for stock options granted during the three months ended June 30, 2015 and 2014 are as follows:
|
Three months ended June 30, |
|
|||
|
2015 |
|
2014 |
|
|
Expected volatility |
N/A |
|
|
85.5 |
% |
Risk-free interest rate |
N/A |
|
|
1.9 |
% |
Expected life (years) |
N/A |
|
|
5.8 |
|
Dividend yield |
None |
|
None |
|
The expected volatility rate was estimated based on an equal weighting of the historical volatility of the Company’s common stock and the implied volatility of the Company’s traded options. The expected term was estimated based on an analysis of the Company’s historical experience of exercise, cancellation, and expiration patterns. The risk-free interest rate is based on the average of the five and seven year United States Treasury rates.
3. Computation of Net Loss per Common Share
Basic net loss per share (“EPS”) is computed by dividing net loss by the weighted-average number of common shares outstanding for the period. Where applicable, diluted EPS is computed by dividing the net loss by the weighted-average number of common shares and dilutive common equivalent shares outstanding during the period, calculated using the treasury stock method. Common equivalent shares include the effect of restricted stock, exercise of stock options and warrants and contingently issuable shares. For the three months ended June 30, 2015, 1.6 million shares were not included in the calculation of diluted EPS as they were considered anti-dilutive, of which 0.4 million relate to unexercised stock options, and 1.2 million relate to outstanding warrants. For the three months ended June 30, 2014, 0.7 million shares were not included in the calculation of diluted EPS as they were considered anti-dilutive, of which 0.4 million relate to unvested stock options, and 0.3 million relate to outstanding warrants.
The following table reconciles the numerators and denominators of the earnings per share calculation for the three months ended June 30, 2015 and 2014 (in thousands, except per share data):
8
|
Three months ended June 30, |
|
||||||
|
2015 |
|
|
|
2014 |
|
||
|
|
|
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
|
|
Net loss |
|
(9,121 |
) |
|
$ |
|
(13,517 |
) |
Denominator: |
|
|
|
|
|
|
|
|
Weighted-average shares of common stock outstanding |
|
12,312 |
|
|
|
|
7,962 |
|
Weighted-average shares subject to repurchase |
|
(201 |
) |
|
|
|
(193 |
) |
Shares used in per-share calculation ― basic |
|
12,111 |
|
|
|
|
7,769 |
|
Shares used in per-share calculation ― diluted |
|
12,111 |
|
|
|
|
7,769 |
|
Net loss per share ― basic |
|
(0.75 |
) |
|
$ |
|
(1.74 |
) |
Net loss per share ― diluted |
|
(0.75 |
) |
|
$ |
|
(1.74 |
) |
4. Fair Value Measurements
A valuation hierarchy for disclosure of the inputs to valuation used to measure fair value has been established. This hierarchy prioritizes the inputs into three broad levels as follows:
|
Level 1 |
- |
Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. |
|
|
|
|
|
Level 2 |
- |
Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). |
|
|
|
|
|
Level 3 |
- |
Unobservable inputs that reflect the Company’s assumptions that market participants would use in pricing the asset or liability. The Company develops these inputs based on the best information available, including its own data. |
The Company provides a gross presentation of activity within Level 3 measurement roll-forward and details of transfers in and out of Level 1 and 2 measurements. A change in the hierarchy of an investment from its current level is reflected in the period during which the pricing methodology of such investment changes. Disclosure of the transfer of securities from Level 1 to Level 2 or Level 3 is made in the event that the related security is significant to total cash and investments. The Company did not have any transfers of assets and liabilities from Level 1 and Level 2 to Level 3 of the fair value measurement hierarchy during the three months ended June 30, 2015.
A financial asset’s or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.
9
The following table provides the assets and liabilities carried at fair value on a recurring basis, measured as of June 30, 2015 and March 31, 2015 (in thousands):
|
Total |
|
|
Quoted Prices in |
|
|
Significant Other |
|
|
Significant |
|
||||
|
Carrying |
|
|
Active Markets |
|
|
Observable Inputs |
|
|
Unobservable Inputs |
|
||||
|
Value |
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
||||
June 30, 2015: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents |
$ |
26,010 |
|
|
$ |
26,010 |
|
|
$ |
- |
|
|
$ |
- |
|
Derivative liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
$ |
2,198 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
2,198 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
Quoted Prices in |
|
|
Significant Other |
|
|
Significant |
|
||||
|
Carrying |
|
|
Active Markets |
|
|
Observable Inputs |
|
|
Unobservable Inputs |
|
||||
|
Value |
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
||||
March 31, 2015: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents |
$ |
12,519 |
|
|
$ |
12,519 |
|
|
$ |
- |
|
|
$ |
- |
|
Derivative liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
$ |
2,999 |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
2,999 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The table below reflects the activity for the Company’s major classes of liabilities measured at fair value on a recurring basis (in thousands):
|
|
|
Warrants |
|
|
April 1, 2015 |
|
|
$ |
2,999 |
|
Mark to market adjustment |
|
|
|
(801 |
) |
Balance at June 30, 2015 |
|
|
$ |
2,198 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants |
|
|
April 1, 2014 |
|
|
$ |
2,601 |
|
Warrant issuance with equity offering |
|
|
|
4,255 |
|
Warrant issuance with senior secured term loan |
|
|
|
106 |
|
Mark to market adjustment |
|
|
|
(3,963 |
) |
Balance at March 31, 2015 |
|
|
$ |
2,999 |
|
The following table provides the assets and liabilities measured at fair value on a non-recurring basis, as of June 30, 2015. During the three months ended June 30, 2015 the Company’s investment in Tres Amigas was determined to be no longer recoverable and was fully impaired. See note 14, “Minority Investments” for further details:
|
Total |
|
|
Quoted Prices in |
|
Significant Other |
|
Significant |
|
||
|
Carrying |
|
|
Active Markets |
|
Observable Inputs |
|
Unobservable Inputs |
|
||
|
Value |
|
|
(Level 1) |
|
(Level 2) |
|
(Level 3) |
|
||
June 30, 2015: |
|
|
|
|
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
Investment in unconsolidated entity – Tres Amigas |
$ |
- |
|
|
$ |
|
$ |
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
Valuation Techniques
Cash Equivalents
Cash equivalents consist of highly liquid instruments with maturities of three months or less that are regarded as high quality, low risk investments and are measured using such inputs as quoted prices, and are classified within Level 1 of the valuation hierarchy. Cash equivalents consist principally of certificates of deposits and money market accounts.
10
Warrants were issued in conjunction with a Securities Purchase Agreement (the “Purchase Agreement”) with Capital Ventures International (“CVI”), an equity offering to Hudson Bay Capital in November 2014, and a Loan and Security Agreement with Hercules Technology Growth Capital, Inc. (“Hercules”). (See Note 10, “Debt,” and Note 11 “Warrants and Derivative Liabilities,” for additional information.) These warrants are subject to revaluation at each balance sheet date, and any change in fair value will be recorded as a change in fair value in derivatives and warrants until the earlier of their exercise or expiration.
The Company relies on various assumptions in a lattice model to determine the fair value of warrants. The Company has valued the warrants within Level 3 of the valuation hierarchy. (See Note 11, “Warrants and Derivative Liabilities,” for a discussion of the warrants and the valuation assumptions used.)
Minority Investment
The Company accounts for the minority investment in Tres Amigas on the equity basis (See Note 14, “Minority Investments”). During the three months ended June 30, 2015, the Company determined that as a result of delays in Tres Amigas securing financing for the project as well as the Company’s projected recovery of its investment based on recent adverse market indicators for potential sales of the Company’s share of the investment, that its investment in Tres Amigas was no longer recoverable and therefore recorded an impairment charge of $0.7 million.
5. Accounts Receivable
Accounts receivable at June 30, 2015 and March 31, 2015 consisted of the following (in thousands):
|
June 30, |
|
|
March 31, |
|
||
|
2015 |
|
|
2015 |
|
||
Accounts receivable (billed) |
$ |
6,601 |
|
|
$ |
8,946 |
|
Accounts receivable (unbilled) |
|
1,944 |
|
|
|
987 |
|
Less: Allowance for doubtful accounts |
|
(54 |
) |
|
|
(54 |
) |
Accounts receivable, net |
$ |
8,491 |
|
|
$ |
9,879 |
|
6. Inventory
Inventory at June 30, 2015 and March 31, 2015 consisted of the following (in thousands):
|
June 30, |
|
|
March 31, |
|
||||||
|
2015 |
|
|
2015 |
|
||||||
Raw materials |
$ |
8,018 |
|
|
$ |
9,411 |
|
||||
Work-in-process |
|
1,092 |
|
|
|
2,117 |
|
||||
Finished goods |
|
6,286 |
|
|
|
7,487 |
|
||||
Deferred program costs |
|
1,684 |
|
|
|
1,581 |
|
||||
Net inventory |
$ |
17,080 |
|
|
$ |
20,596 |
|
The Company recorded inventory write-downs of $0.6 million for each of the three months ended June 30, 2015 and 2014. These write downs were based on evaluating its inventory on hand for excess quantities and obsolescence.
Deferred program costs as of June 30, 2015 and March 31, 2015 primarily represent costs incurred on programs accounted for under contract accounting where the Company needs to complete development milestones before revenue and costs will be recognized.
7. Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses at June 30, 2015 and March 31, 2015 consisted of the following (in thousands):
11
|
June 30, |
|
|
March 31, |
|
||
|
2015 |
|
|
2015 |
|
||
Accounts payable |
$ |
6,613 |
|
|
$ |
7,062 |
|
Accrued inventories in-transit |
|
964 |
|
|
|
1,127 |
|
Accrued miscellaneous expenses |
|
2,969 |
|
|
|
2,695 |
|
Accrued outside services |
|
684 |
|
|
|
582 |
|
Accrued compensation |
|
3,545 |
|
|
|
5,937 |
|
Income taxes payable |
|
526 |
|
|
|
278 |
|
Accrued warranty |
|
3,344 |
|
|
|
3,934 |
|
Total |
$ |
18,645 |
|
|
$ |
21,615 |
|
The Company generally provides a one to three year warranty on its products, commencing upon installation. A provision is recorded upon revenue recognition to cost of revenues for estimated warranty expense based on historical experience.
Product warranty activity was as follows (in thousands):
|
Three months ended |
|
|||||
|
June 30, |
|
|||||
|
2015 |
|
|
2014 |
|
||
Balance at beginning of period |
$ |
3,934 |
|
|
$ |
3,207 |
|
Change in accruals for warranties during the period |
|
(5 |
) |
|
|
(72 |
) |
Settlements during the period |
|
(585 |
) |
|
|
(280 |
) |
Balance at end of period |
$ |
3,344 |
|
|
$ |
2,855 |
|
8. Income Taxes
The Company recorded income tax expense of $0.6 million and $0.1 million for the three months ended June 30, 2015, and 2014, respectively. Income tax expense was primarily due to income taxes in the Company’s foreign jurisdictions.
9. Restructuring
The Company accounts for charges resulting from operational restructuring actions in accordance with ASC Topic 420, Exit or Disposal Cost Obligations (“ASC 420”) and ASC Topic 712, Compensation—Nonretirement Postemployment Benefits (“ASC 712”). In accounting for these obligations, the Company is required to make assumptions related to the amounts of employee severance, benefits, and related costs and the time period over which leased facilities will remain vacant, sublease terms, sublease rates and discount rates. Estimates and assumptions are based on the best information available at the time the obligation arises. These estimates are reviewed and revised as facts and circumstances dictate; changes in these estimates could have a material effect on the amount accrued on the consolidated balance sheet.
During the years ended March 31, 2015 and 2014, the Company undertook restructuring activities, approved by the Board of Directors, in order to reorganize its global operations, streamline various functions of the business, and reduce its global workforce to better reflect the demand for its products. During the year ended March 31, 2014, the Company undertook a plan to consolidate its Grid manufacturing activities in its Devens, Massachusetts facility and close its facility in Middleton, Wisconsin which was completed during the year ended March 31, 2015. In addition, the Company established a new Wind manufacturing facility in Romania and as a result reduced the headcount in its operation in China. The Company is maintaining its headcount in China at a level necessary to support demand from its Chinese customers. The Company recorded restructuring charges for severance and other costs of approximately $1.2 million during the three months ended June 30, 2014, primarily associated with the consolidation of the Company’s Grid manufacturing activities in the United States. From April 1, 2011 through June 30, 2015, the Company’s various restructuring activities resulted in a substantial reduction of its global workforce. Remaining unpaid amounts under these restructuring activities are expected to be paid by August 31, 2015.
12
The following table presents restructuring charges and cash payments (in thousands):
|
Severance pay |
|
|
Facility exit and |
|
|
|
|
|
||
Three months ended June 30, 2015 |
and benefits |
|
|
Relocation costs |
|
|
Total |
|
|||
Accrued restructuring balance at April 1, 2015 |
$ |
180 |
|
|
$ |
- |
|
|
$ |
180 |
|
Cash payments |
|
(162 |
) |
|
|
- |
|
|
|
(162 |
) |
Accrued restructuring balance at June 30, 2015 |
$ |
18 |
|
|
$ |
- |
|
|
$ |
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Severance pay |
|
|
Facility exit and |
|
|
|
|
|
||
Three months ended June 30, 2014 |
and benefits |
|
|
Relocation costs |
|
|
Total |
|
|||
Accrued restructuring balance at April 1, 2014 |
$ |
844 |
|
|
$ |
- |
|
|
$ |
844 |
|
Charges to operations |
|
690 |
|
|
|
489 |
|
|
|
1,179 |
|
Cash payments |
|
(589 |
) |
|
|
(489 |
) |
|
|
(1,078 |
) |
Accrued restructuring balance at June 30, 2014 |
$ |
945 |
|
|
$ |
- |
|
|
$ |
945 |
|
All restructuring charges discussed above are included within restructuring and impairments in the Company’s unaudited condensed consolidated statements of operations. The Company includes accrued restructuring within accounts payable and accrued expenses in the unaudited condensed consolidated balance sheets.
10. Debt
On June 5, 2012, the Company entered into a Loan and Security Agreement with Hercules, (the “Term Loan”), under which the Company borrowed $10.0 million. After the closing fees and expenses, the net proceeds to the Company were $9.7 million. The Term Loan bears an interest rate equal to 11% plus the percentage, if any, by which the prime rate as reported by The Wall Street Journal exceeds 3.75%. The Company made interest-only payments from July 1, 2012 through October 31, 2012, after which the Company began repaying the Term Loan in equal monthly installments ending on December 1, 2014, when the loan was repaid in full. In addition, Hercules received a warrant (the “First Warrant”) to purchase 13,927 shares of common stock, exercisable at an initial strike price of $35.90 per share, subject to adjustment, until December 5, 2017. Due to certain adjustment provisions within the warrant, it qualified for liability accounting and the fair value of $0.4 million was recorded upon issuance, which the Company recorded as a debt discount and a warrant liability. The total debt discount including the First Warrant, end of term fee and legal and origination costs of $1.2 million was amortized into interest expense over the term of the Term Loan using the effective interest method. Under this method, interest expense was recognized each period until the debt instrument reached maturity. During the three months ended June 30, 2014, the Company recorded non-cash interest expense for amortization of the debt discount related to the Term Loan of $0.1 million.
On November 15, 2013, the Company amended the Term Loan with Hercules and entered into a new term loan (the “New Term Loan B”), borrowing an additional $10.0 million. After closing fees and expenses, the net proceeds to the Company for the New Term Loan B were $9.8 million. The New Term Loan B bears the same interest rate as the Term Loan. The Company is repaying the New Term Loan B in equal monthly installments ending on November 1, 2016. The principal balance of the New Term Loan B is approximately $5.7 million as of June 30, 2015. Hercules received a warrant (the “Second Warrant”) to purchase 25,641 shares of common stock, exercisable at an initial strike price of $19.50 per share, subject to adjustment, until May 15, 2019. In addition, the exercise price of the First Warrant was reduced to $19.50 per share. (See Note 11, “Warrants and Derivative Liabilities,” for a discussion on both warrants and the valuation assumptions used.) The Company will pay an end of term fee of $0.5 million upon the earlier of maturity or prepayment of the New Term Loan B. The Company has accrued the end of term fee and recorded a corresponding amount into the debt discount. The New Term Loan B includes a mandatory prepayment feature which allows Hercules the right to use any of the Company’s net proceeds from specified asset dispositions greater than $1.0 million in a calendar year to pay off any outstanding accrued interest and principal balance on the New Term Loan B. The Company determined the fair value to be deminimis for this feature. In addition, the Company incurred $0.2 million of legal and origination costs in the three months ended December 31, 2013, which have been recorded as a debt discount. The total debt discount including the Second Warrant, end of term fee and legal and origination costs of $1.0 million is being amortized into interest expense over the term of the New Term Loan B using the effective interest method. During both the three months ended June 30, 2015 and 2014 the Company recorded non-cash interest expense for amortization of the debt discount related to the New Term Loan B of $0.1 million.
13
On December 19, 2014, the Company entered into an amendment with Hercules (the “Hercules Second Amendment”) and entered into a new term loan (the “New Term Loan C”), borrowing an additional $1.5 million. After closing fees and expenses, the net proceeds to the Company for the New Term Loan C were $1.4 million. The Term Loan, New Term Loan B and New Term Loan C are collectively referred to as the “Term Loans”. The New Term Loan C also bears the same interest rate as the other Term Loans. The Company will make interest only payments until maturity on June 1, 2017, when the loan is scheduled to be repaid in its entirety. The maturity date of the New Term Loan C was extended from March 1, 2017 to June 1, 2017 due to the Company’s April 2015 equity offering which raised more than $10 million in new capital before December 31, 2015. In conjunction with the Hercules Second Amendment, the First and Second Warrants were cancelled and replaced with the issuance of a new warrant (the “Warrant”) to purchase 58,823 shares of common stock at an exercise price of $11.00 per share, subject to adjustment. The Warrant expires on June 30, 2020. (See Note 11, “Warrants and Derivative Liabilities”, for a discussion on the Warrant and the valuation assumptions used.) The Company will pay an end of term fee of approximately $0.1 million upon earlier of maturity or prepayment of the New Term Loan C. The Company has accrued the end of term fee and recorded a corresponding amount in the debt discount. The New Term Loan C includes the same mandatory prepayment feature as the New Term Loan B. The Company determined the fair value to be de-minimus for this feature. In addition, the Company incurred approximately $0.1 million of legal and origination costs in the three months ended December 31, 2014, which have been recorded as a debt discount. The total debt discount, including the Warrant, end of term fee and legal and origination costs of $0.3 million is being amortized into interest expense over the term of the New Term Loan C using the effective interest method. During the three months ended June 30, 2015, the Company recorded non-cash interest expense for amortization of the debt discount related to the New Term Loan C of less than $0.1 million. If the maturity of any of the Term Loans is accelerated because of prepayment, then the amortization will be accelerated.
The Term Loans are secured by substantially all of the Company’s existing and future assets, including a mortgage on real property owned by the Company’s wholly-owned subsidiary, ASC Devens LLC, and located at 64 Jackson Road, Devens, Massachusetts. The Term Loans contain certain covenants that restrict the Company’s ability to, among other things, incur or assume certain debt, merge or consolidate, materially change the nature of the Company’s business, make certain investments, acquire or dispose of certain assets, make guaranties or grant liens on its assets, make certain loans, advances or investments, declare dividends or make distributions or enter into transactions with affiliates. In addition, there is a covenant that requires the Company to maintain a minimum unrestricted cash balance (the “Minimum Threshold”) in the United States. As part of the Hercules Second Amendment, this Minimum Threshold was amended to be the lower of $5.0 million or the aggregate outstanding principal balance of the Term Loans. As a result of the Company’s April 2015 equity offering, the Minimum Threshold was reduced to the lesser of $2.0 million or the aggregate outstanding principal balance of the Term Loans. As of June 30, 2015 the Minimum Threshold was $2.0 million. The events of default under the Term Loans include, but are not limited to, failure to pay amounts due, breaches of covenants, bankruptcy events, cross defaults under other material indebtedness and the occurrence of a material adverse effect and/or change in control. In the case of a continuing event of default, Hercules may, among other remedies, declare due all unpaid principal amounts outstanding and any accrued but unpaid interest and foreclose on all collateral granted to Hercules as security under the Term Loans.
Although the Company believes that it is in and expects to remain in compliance with the covenants and restrictions under the Term Loans as of June 30, 2015, there can be no assurance that the Company will continue to be in compliance.
Interest expense on the Term Loans for the three months ended June 30, 2015, and 2014, was $0.3 million, and $0.5 million, respectively, which included $0.1 million and $0.2 million, respectively, of non-cash interest expense related to the amortization of the debt discount on the Term Loans.
14
11. Warrants and Derivative Liabilities
Senior Convertible Note Warrant
On April 4, 2012, the Company entered into the Purchase Agreement with CVI. The Purchase Agreement included a warrant (the “Original Warrant”) to purchase 309,406 shares of the Company’s common stock. The Original Warrant is exercisable at any time on or after the date that is six months after the issuance of the Original Warrant and entitles CVI to purchase shares of the Company’s common stock for a period of five years from the initial date the original warrant becomes exercisable at an initial exercise price equal to $54.50 per share, subject to certain price-based and other anti-dilution adjustments. On October 9, 2013, the Company amended the Purchase Agreement with CVI (the “Amendment”). Pursuant to the Amendment, the Company exchanged the Original Warrant for a new warrant (the “Exchanged Warrant”), with a reduced exercise price of $26.10 per share of common stock. Other than the reduced exercise price, the Exchanged Warrant has the same terms and conditions as the Original Warrant. As a result of the sales of common stock under an At Market Sales Arrangement (“ATM”) and the 909,090 units, each consisting of one share of common stock and 0.90 of a warrant to purchase one share of common stock, sold to Hudson Bay Capital during the three months ended December 31, 2014, the exercise price of the Exchanged Warrant was further reduced to $22.10 per share. As a result of the April 2015 equity offering (see Note 12, “Stockholders Equity”), the exercise price of the Exchanged Warrant was further reduced to $15.94 per share. The Exchanged Warrant may not be exercised if, after giving effect to the conversion, CVI together with its affiliates, would beneficially own in excess of 4.99% of the Company’s common stock. This percentage may be raised to any other percentage not in excess of 9.99% at the option of CVI, upon at least 61-days prior notice to the Company, or lowered to any other percentage, at the option of CVI, at any time.
The Company calculated the fair value of the Exchanged Warrant, (see Note 4, “Fair Value Measurements” for further discussion), utilizing an integrated lattice model. The lattice model is an option pricing model that involves the construction of a binomial tree to show the different paths that the underlying asset may take over the option’s life. A lattice model can take into account expected changes in various parameters such as volatility over the life of the options, providing more accurate estimates of option prices than the Black-Scholes model.
The Company accounts for the Exchanged Warrant as a liability due to certain adjustment provisions within the warrant, which requires that it be recorded at fair value. The Exchanged Warrant is subject to revaluation at each balance sheet date and any change in fair value is recorded as a change in fair value of derivatives and warrants until the earlier of its expiration or its exercise at which time the warrant liability will be reclassified to equity.
Following is a summary of the key assumptions used to calculate the fair value of the Exchanged Warrant:
|
June 30, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year 15 |
2015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
0.74 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected annual dividend yield |
|
— |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected volatility |
|
71.61 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term (years) |
2.26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value |
$0.2 million |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
December 31, |
|
|
September 30, |
|
|
June 30, |
|
|
March 31, |
|
|||||
Fiscal Year 14 |
2015 |
|
|
2014 |
|
|
2014 |
|
|
2014 |
|
|
2014 |
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk-free interest rate |
|
0.73 |
% |
|
|
1.00 |
% |
|
|
1.07 |
% |
|
|
0.98 |
% |
|
|
1.11 |
% |
Expected annual dividend yield |
|
— |
% |
|
|
— |
% |
|
|
— |
% |
|
|
— |
% |
|
|
— |
% |
Expected volatility |
|
70.42 |
% |
|
|
72.38 |
% |
|
|
76.20 |
% |
|
|
83.50 |
% |
|
|
80.99 |
% |
Term (years) |
2.51 |
|
|
2.76 |
|
|
3.01 |
|
|